#insulin4all USA
T1International Statement on HR 6833 and the Affordable Insulin Now Act Vote
31 Mar 2022, 8 p.m. in #insulin4all USA, News & Statements, Press Inquiries by T1International
On Thursday, March 31st, the US House of Representatives voted to pass a $35 insulin copay cap. The bill now heads to the Senate. While a $35 copay cap on insulin would impact many people, T1International is calling on the Senate to pass a true price cap on insulin for everyone, especially those without insurance. Read more
The Next 100 Years of Insulin
24 Mar 2022, 11:11 p.m. in #insulin4all USA, Global Stories, News & Statements by Ian Devaney
For some, the first 100 years of insulin has been a great, life-affirming success. For others, it has been a failure, where leaders and organizations in power have chosen profits over the lives and welfare of human beings. So how will we shape the next 100 years? Read more
6 Strategies for Ethical Patient Engagement
18 Feb 2022, 10:33 a.m. in #insulin4all USA, News & Statements by T1International
More and more organisations today, from NGOs to global health alliances, are expressing a need for patient engagement and claiming to be patient-informed. As a patient-led organisation, we have noted that patient engagement is often well-intentioned but misguided. While patients might be acknowledged as experts on an event flyer or web page, that expert status does not necessarily mean they are compensated equitably or that their perspectives are valued and/or integrated comparably to other accepted experts, such as physicians or academic researchers. Read more
Greed v. Alec’s Law: Oral Argument at the Eighth Circuit
15 Dec 2021, 2:12 p.m. in #insulin4all USA, News & Statements by Jesus Morales Sanchez
T1International is proud to join T1International’s Minnesota #insulin4all Chapter and patient advocates at the oral argument before the United States Court of Appeals for the Eighth Circuit (Eighth Circuit) in support of upholding Minnesota’s Alec Smith Insulin Affordability Act (Alec’s Law) on December 15, 2021. Read more
T1International Publishes Survey on Type 1 Diabetes, COVID, and Insulin Rationing
18 Oct 2021, 3:15 p.m. in #insulin4all USA, News & Statements by T1International
In September 2021, T1International’s latest out-of-pocket cost survey was published in the Journal of Diabetes Research and Clinical Practice. Conducted every two years, this study is the most comprehensive patient-led out-of-pocket cost survey for people living with type 1 diabetes. Read more
T1International Hosts 3rd Annual #insulin4all Workshop
13 Sep 2021, 6:38 p.m. in #insulin4all USA, News & Statements by T1International
Join us for T1International’s annual #insulin4all Workshop: Advocate, Don’t Celebrate. This event is an opportunity for advocates from around the world to learn from each other, build community, and take action in the fight for #insulin4all. Read more
Redirecting Guilt into Action
16 Jul 2021, 10:04 a.m. in #insulin4all USA, Global Stories by Elizabeth Roosevelt
It’s crucial that those of us who have access to insulin use our platform and privilege to fight for our community and for the people with diabetes who are solely focused on surviving. We must serve as the voice for the people with diabetes who can’t use their own because they’re bogged down working three jobs and choosing between putting food on the table for their family or insulin. Read more
Underrepresented Communities and Navigating the System
14 Jun 2021, 12:52 p.m. in #insulin4all USA, Global Stories by Alzahrra Almajid
Seven years after my diagnosis my brother was also diagnosed with type 1 diabetes which made the already bad financial burden worse. Although all people with diabetes struggle with how expensive diabetes can be, immigrants and people of color often do not have access to quality health insurance (or any access) so they are less likely to benefit from advanced diabetes technology. As I got older I began to understand how difficult it is to navigate a system that makes it harder for people in underrepresented communities to get adequate care. Read more
Why MODY Should be Included in #insulin4all
28 Apr 2021, 1:27 p.m. in #insulin4all USA by Kylie Hanson Kulwicki
Most people don’t know the difference between type 1 and type 2 diabetes, let alone that there are more than 2 types. I have a form of diabetes called Maturity Onset Diabetes of the Young, or MODY for short. MODY is a genetic form of diabetes caused by a gene mutation or a gene deletion. Read more
Insulin is a Right for Incarcerated People with Diabetes
24 Mar 2021, 9:06 a.m. in #insulin4all USA, Global Stories by Elana Megerian
It is time to recognize that incarcerated people with diabetes are particularly vulnerable to insulin insecurity. #insulin4all is more than a hashtag: It is a rallying call to everyone impacted by insulin inaccessibility, and a mournful cry for all who have lost their lives while insulin remains clearly in view, but cruelly out of reach. It’s a demand for justice for everyone who needs insulin to survive, including incarcerated people with diabetes. We must find ways to meaningfully include and involve this population in our activism. Read more